rs397508141
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM4PP3PP5_Very_Strong
The NM_000492.4(CFTR):c.100_117delTTGTCAGACATATACCAA(p.Leu34_Gln39del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000492.4 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.100_117delTTGTCAGACATATACCAA | p.Leu34_Gln39del | conservative_inframe_deletion | Exon 2 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:3Other:1
- -
- -
This variant, c.100_117del, results in the deletion of 6 amino acid(s) of the CFTR protein (p.Leu34_Gln39del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of cystic fibrosis (PMID: 17718859, 26500004, 31199594). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as 232del18. ClinVar contains an entry for this variant (Variation ID: 53164). For these reasons, this variant has been classified as Pathogenic. -
The c.100_117del18 variant (also known as p.L34_Q39del) is located in coding exon 2 of the CFTR gene. This variant results from an in-frame TTGTCAGACATATACCAA deletion at nucleotide positions 100 to 117. This results in the in-frame deletion of six amino acids between codons 34 and 39. This alteration has been identified in multiple individuals with suspected Cystic Fibrosis, however, further details were not provided (Pepermans X et al. Clin Biochem, 2016 Jan;49:154-60; Cambraia A et al. Dis Markers, 2021 Feb;2021:9812074). Additionally, this alteration was identified in two individuals with Cystic Fibrosis based on positive sweat tests and pancreatic insufficiency. Both individuals also carried F508del, one confirmed in trans (Faucz FR et al. Clin Genet, 2007 Sep;72:218-23; Martins RDS et al. Mol Genet Genomic Med, 2019 07;7:e00645). This amino acid region is highly conserved in available vertebrate species. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at